tirzepatide and vertigo GLP-1 meds like semaglutide (Ozempic/Wegovy) (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular vertigo and tirzepatide vertigo from

Description

4A), suggesting that GLP-1R deletion resulted in reduced functional connectivity across the brain

Related Reading Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Glp 1 Medications Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications Can You Get Your Glp 1 Tested Pricing and availability current as of June 2026

Giuseppe Floresta, assistant professor in the department of drug and health sciences at the University of Catania in Italy, and Dr

2019Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

A clinical trial published in the New England Journal of Medicine found that participants who used Semaglutide experienced an average weight loss of 14.9% of their initial body weight over a 68-week period